Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Steve Tauscher who wrote (25687)	9/23/1998 6:36:00 AM
From: Henry Niman	Read Replies (2) \| Respond to of 32384

The deal is quite big and should be a major plus for MLNM. The European drug companies have been on the prowl, and a deal this size should be a signal for the entire Biotech sector.

To: Steve Tauscher who wrote (25687)	9/23/1998 8:05:00 AM
From: Henry Niman	Respond to of 32384

CNBC has mentioned the MLNM deal and they also mentioned that "Biotechs are on a Roll".

To: Steve Tauscher who wrote (25687)	9/23/1998 10:46:00 AM
From: Cheryl Galt	Read Replies (1) \| Respond to of 32384

Hi Steve. No, IR never answered my email asking about Ron Evans. I'll try again. I seem to recall Henry saying that Susan A. was away from San Diego for two weeks, and I sent my email at the START of that away time. --------------- But LOOK here, at the Faculty Page for the Salk Institute for Biological Studies. Scroll down and Click, to see a PICTURE of Ron Evans Ph.D., University of California, Los Angeles, 1974 salk.edu --------------------- For some reason, on this impersonal, anonomous-feeling Internet, I like to see PICTURES. They seem to impart a dose of SUBSTANCE. <G> I'll bet this picture of Ron is 24 years old. I like MY 24-year-old pictures better too! <G> Cheryl PS Henry, Does Pitt have a faculty page with pictures ?